Artemisinin Antimalarials: Preserving the 'Magic Bullet'
2010

Artemisinin Antimalarials: Preserving the 'Magic Bullet'

Sample size: 2099 publication Evidence: high

Author Information

Author(s): Maude Richard J, Woodrow Charles J, White Lisa J

Primary Institution: Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University

Hypothesis

How can the effectiveness of artemisinin antimalarials be preserved in the face of emerging resistance?

Conclusion

The artemisinins are crucial for malaria treatment, but emerging resistance poses a significant threat to their effectiveness.

Supporting Evidence

  • Artemisinin has been used in traditional medicine for over 2000 years.
  • Clinical trials have shown artemisinin to be superior to other antimalarials.
  • Resistance to other antimalarials has increased, making artemisinin crucial.
  • Combination therapies with artemisinin are recommended to prevent resistance.

Takeaway

Artemisinin is a super medicine that helps fight malaria, but we need to be careful because some germs are starting to resist it.

Methodology

The study reviews historical and clinical data on artemisinin and its derivatives, including trials and efficacy assessments.

Potential Biases

Potential bias due to the historical context and limited publication of Chinese trial data.

Limitations

Limited availability of artemisinin and concerns about resistance development.

Participant Demographics

Patients with malaria, including those with Plasmodium falciparum and vivax.

Digital Object Identifier (DOI)

10.1002/ddr.20344

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication